Teva Pharmaceutical Industries
TEVA
$7.23
Share price
0.42%
Change (1 day)
-22.26%
Change (1 year)
Categories
Teva Pharmaceutical Industries (TEVA) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : $35.31 B
According to Teva Pharmaceutical Industries's latest financial reports the company's total liabilities are $35.31 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Teva Pharmaceutical Industries - Total liabilities on balance sheet (from 2001 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $35.31 B | -3.04% |
| 2021-12-31 | $36.42 B | -7.98% |
| 2020-12-31 | $39.57 B | -6.67% |
| 2019-12-31 | $42.40 B | -5.53% |
| 2018-12-31 | $44.88 B | -13.46% |
| 2017-12-31 | $51.87 B | -10.41% |
| 2016-12-31 | $57.89 B | 137.96% |
| 2015-12-31 | $24.33 B | 5.49% |
| 2014-12-31 | $23.06 B | -7.27% |
| 2013-12-31 | $24.87 B | -10.35% |
| 2012-12-31 | $27.74 B | -0.21% |
| 2011-12-31 | $27.79 B | 72.13% |
| 2010-12-31 | $16.15 B | 10.99% |
| 2009-12-31 | $14.55 B | -12.05% |
| 2008-12-31 | $16.54 B | 71.4% |
| 2007-12-31 | $9.65 B | 3.85% |
| 2006-12-31 | $9.29 B | 114.29% |
| 2005-12-31 | $4.33 B | 2.48% |
| 2004-12-31 | $4.23 B | 61.55% |
| 2003-12-31 | $2.61 B | -6.18% |
| 2002-12-31 | $2.79 B | 34.43% |
| 2001-12-31 | $2.07 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $60.09 B | 70.18% | 🇨🇭 Switzerland |
 Pfizer PFE | $101.28 B | 186.82% | 🇺🇸 USA |
 Sanofi SNY | $55.23 B | 56.39% | 🇫🇷 France |
 Merck MRK | $63.10 B | 78.68% | 🇺🇸 USA |
 AstraZeneca AZN | $60.87 B | 72.38% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $58.57 B | 65.86% | 🇬🇧 UK |
 Dr. Reddy's RDY | $1.04 B | -97.05% | 🇮🇳 India |